Dec 21 (Reuters) - Bellus Health Inc BLU.TO
* Bellus Health provides update on pipeline
* Auven Therapeutics has decided to terminate Kiacta program for treatment of AA Amyloidosis
* Continues to explore opportunities in order to expand its pipeline, including through acquisitions and/or in-licensing Source text for Eikon: Further company coverage: BLU.TO